• Explore /
  • Poster
  • / SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery.

SWOG S0307 phase III trial of bisphosphonates as adjuvant therapy in primary breast cancer: Comparison of toxicities and patient-stated preference for oral versus intravenous delivery.

Abstract Poster

Authors

Julie Gralow

Julie Gralow

University of Washington, School of Medicine, Seattle, WA

Julie Gralow , William E. Barlow , Alexander H. G. Paterson , Danika Lew , Alison Stopeck , Daniel F. Hayes , Dawn L. Hershman , Mark Schubert , Mark Clemons , Catherine H. Van Poznak , Elizabeth Claire Dees , James N. Ingle , Carla Isadora Falkson , Anthony D. Elias , Michael J. Messino , Jeffrey H. Margolis , Shaker R. Dakhil , Helen K. Chew , Robert B. Livingston , Gabriel N. Hortobagyi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2014 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

ER+

Clinical Trial Registration Number

NCT00127205

Citation

J Clin Oncol 32:5s, 2014 (suppl; abstr 558)

DOI

10.1200/jco.2014.32.15_suppl.558

Abstract #

558

Poster Bd #

22

Abstract Disclosures

Similar Posters

First Author: Darya Kizub

First Author: Raul A Herrera Pena

First Author: Walter Gregory

First Author: Katherine Elizabeth Reeder-Hayes